The Lancet: Phase 3 trial reports one dose of Ad5-nCoV COVID-19 vaccine is safe and effective, including against severe disease
This item is under embargo and is only visible to journalists
Please login here
Regions: Europe, United Kingdom, Russian Federation, Asia, China, Pakistan, Latin America, Argentina, Chile, Mexico, North America, United States
Keywords: , Covid-19, Health, Medical
The item has been withdrawn. If you are a journalists please contact the person that posted the item with any questions.